降压药物与视网膜神经纤维层及神经节细胞-内丛状层厚度的关联
该基于人群的横断面研究纳入9144只眼分析RNFL、8549只眼分析GC-IPL,对象为44至86岁无青光眼多族裔亚洲人。调整年龄、性别、族裔、MAP、IOP、BMI及糖尿病后,使用任何降压药、ACEI或利尿剂与平均RNFL更薄相关,用药种类越多RNFL越薄,GC-IPL呈类似趋势。
要点
- 使用任何降压药、ACEI或利尿剂与平均RNFL更薄独立相关。
- 降压药种类越多,平均RNFL越薄(趋势P=0.001)。
- ACEI和利尿剂使用者的下方RNFL象限变薄最明显。
核心结论
- 使用2种及以上降压药、ACEI或利尿剂与视网膜神经节细胞健康的结构标志物丢失相关。
研究设计与样本
- 基于人群的横断面研究,纳入9144只眼分析RNFL(马来人2668、印度人3554、华人2922),8549只眼分析GC-IPL(马来人2460、印度人3230、华人2859),年龄44至86岁。
主要发现
- 调整年龄、性别、族裔、MAP、IOP、BMI及糖尿病后,使用任何降压药者平均RNFL较未使用者薄(β=-0.83;95%CI -1.46至-0.02;P=0.01)。
- 使用ACEI者平均RNFL更薄(β=-1.66;95%CI -2.57至-0.75;P<0.001),使用利尿剂者平均RNFL更薄(β=-1.38;95%CI -2.59至-0.17;P<0.05)。
- 使用降压药种类越多与平均RNFL越薄显著相关(趋势P=0.001)。
- 使用ACEI者下方RNFL象限更薄(β=-2.44;95%CI -3.99至-0.89;P=0.002),使用利尿剂者下方RNFL象限更薄(β=-2.76;95%CI -4.76至-0.76;P=0.007)。
- 黄斑GC-IPL厚度分析中观察到类似趋势。
临床怎么用
- 在解读无青光眼人群的OCT RNFL和GC-IPL厚度时,可考虑降压药物使用史尤其是ACEI、利尿剂及多药联合治疗的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the association between different classes of antihypertensive medication with retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) thickness in a nonglaucomatous multiethnic Asian population. DESIGN: Population-based, cross-sectional study. PARTICIPANTS: A total of 9144 eyes for RNFL analysis (2668 Malays, 3554 Indians, and 2922 Chinese) and 8549 eyes for GC-IPL analysis (2460 Malays, 3230 Indians, and 2859 Chinese) aged 44 to 86 years. METHODS: Participants underwent standardized systemic and ocular examinations and interviewer-administered questionnaires for collection of data on medication and other variables. Intraocular pressure (IOP) readings were obtained by Goldmann applanation tonometry before pupil dilation for fundoscopy and OCT imaging. Blood pressure (BP) was measured with an automatic BP monitor. Mean arterial pressure (MAP) was defined as diastolic BP plus 1/3 (systolic BP - diastolic BP). Regression models were used to investigate the association of antihypertensive medication with OCT measurements of RNFL and GC-IPL. MAIN OUTCOME MEASURES: Average and sectoral RNFL and GC-IPL thickness. RESULTS: After adjusting for age, gender, ethnicity, MAP, IOP, body mass index (BMI), and presence of diabetes, we found that participants taking any type of antihypertensive medication (β = -0.83; 95% confidence interval [CI], -1.46 to -0.02; P = 0.01), specifically angiotensin-converting enzyme inhibitors (ACEIs) (β = -1.66; 95% CI, -2.57 to -0.75; P < 0.001) or diuretics (β = -1.38; 95% CI, -2.59 to -0.17; P < 0.05), had thinner average RNFL in comparison with participants who were not receiving antihypertensive treatment. Use of a greater number of antihypertensive medications was significantly associated with thinner average RNFL (P for trend = 0.001). This association was most evident in the inferior RNFL quadrant in participants using ACEIs (β = -2.44; 95% CI, -3.99 to -0.89; P = 0.002) or diuretics (β = -2.76; 95% CI, -4.76 to -0.76; P = 0.007). A similar trend was noted in our analysis of macular GC-IPL thickness. CONCLUSIONS: Use of 2 or more antihypertensive medications, ACEI, and diuretics were associated with a loss of structural markers of retinal ganglion cell health in a multiethnic Asian population.
引用
- Chong RS, Chee ML, Tham YC, et al. Association of Antihypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness. Ophthalmology. 2020. PMID: 32739337. doi:10.1016/j.ophtha.2020.07.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。